[Characteristics of the course and treatment of suppurative-septic complications in patients with cervical cancer].

The paper deals with the study of the clinical course of pyo-septic complications of complex radiation treatment for cervical carcinoma. Application of the combined method prevents complications in patients with stage I and IIa tumors with concomitant encapsulated purulent inflammation in the appendages. Treatment for stage IIb and III malignancies should start with removal of the purulent foci.

[Evaluation of a method of chemosurgical treatment of malignant ovarian tumors].

Retrospectively, an efficacy of the two main variants of the primary combined therapy for serous cystadenocarcinoma was estimated: "surgery+chemotherapy" (552 patients) and "chemotherapy+surgery" (253 patients). Both variants resulted in rather high incidence (83.5% and 81.

[Clinical evaluation of the complex diagnosis of ovarian tumors].

For earlier recognition of ovarian tumors the complex diagnosis for ovarian tumors was estimated clinically. The conception is supported concerning females that should be classified as ovarian cancer high-risk groups. A system is elaborated for active identification of patients with ovarian tumors, using the complex diagnosis, the latter in vast majority of cases enables the difficulties of the differential diagnostics to be overcome; also the indications to and sequence of application of the recommended methods of investigation are formulated, some practical recommendation are given.

[Value of dispensary examination for the earliest possible detection of malignant ovarian tumors].

A comparative estimation of the results of dispensary observation, based on the data of only gynecological study and effective dispensary control with the organization of high-risk groups and application of the complex diagnostics system, proved the rationale to raise the question on the need of effective recognition of patients with ovarian tumors. The effective dispensary control was found to enable the detection of ovarian tumors with an adequate reliability in 93.6%; (versus 22.